EUVIMEDEUVIMED entdecken
Open Access

Population Pharmacokinetic-pharmacodynamic Model Analysis of Dapagliflozin for HbA1c-lowering Effects in Japanese Patients with Type 2 Diabetes Mellitus using Long-term Real-world Data

Shinji Kobuchi, Shuhei Sakai, Ryosuke Terada, Ken-Ichiro Kato, Tetsuo Hayakawa, Toshiyuki Sakaeda

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.111519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Shinji Kobuchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto 607-8414, Japan. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Diabetes Mellitus, Type 2, Glucosides, Glycated Hemoglobin. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsDiabetes Mellitus, Type 2GlucosidesGlycated HemoglobinSodium-Glucose Transporter 2 InhibitorsHumansMaleFemaleMiddle AgedAgedModels, BiologicalJapanAdultTreatment OutcomeBlood GlucoseHypoglycemic AgentsEast Asian People

Stichwörter der Autor:innen

long-termpopulation PK model analysispopulation PK-PD model analysisreal-world

Substanzen

dapagliflozinBenzhydryl CompoundsGlucosidesGlycated Hemoglobinhemoglobin A1c protein, humanSodium-Glucose Transporter 2 InhibitorsBlood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • Department Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto 607-8414, Japan.
  • Department of Diabetes Mellitus and Endocrinology, Tonami General Hospital, Toyama 939-1395, Japan.

Zitieren

APA

Kobuchi, S., Sakai, S., Terada, R., Kato, K. I., Hayakawa, T., & Sakaeda, T. (2025). Population Pharmacokinetic-pharmacodynamic Model Analysis of Dapagliflozin for HbA1c-lowering Effects in Japanese Patients with Type 2 Diabetes Mellitus using Long-term Real-world Data. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.111519

Vancouver

Kobuchi S, Sakai S, Terada R, Kato KI, Hayakawa T, Sakaeda T. Population Pharmacokinetic-pharmacodynamic Model Analysis of Dapagliflozin for HbA1c-lowering Effects in Japanese Patients with Type 2 Diabetes Mellitus using Long-term Real-world Data. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.111519

BibTeX
@article{Kobuchi2025,
  author = {Kobuchi, Shinji and Sakai, Shuhei and Terada, Ryosuke and Kato, Ken-Ichiro and Hayakawa, Tetsuo and Sakaeda, Toshiyuki},
  title = {Population Pharmacokinetic-pharmacodynamic Model Analysis of Dapagliflozin for HbA1c-lowering Effects in Japanese Patients with Type 2 Diabetes Mellitus using Long-term Real-world Data},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.111519}
}
Kostenlos starten →